Follow the AMN Healthcare Services INC share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, AMN Healthcare Services INC has published 183 reports. Market capitalisation: €1.3bn. The latest transaction was reported on 17 June 2026 (Cession). Among the most active insiders: Jackson Denise L. Every trade is accessible without an account.
Analysts rate AMN Healthcare Services INC Hold (neutral), based on 7 analysts. Average price target: US$29.86.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 183 declarations
AMN Healthcare Services, Inc. (ticker: AMN) is a US-listed company on the NYSE in the United States (United States), focused on healthcare workforce solutions and medical staffing. For French-speaking investors, AMN is best understood as an operating partner to hospitals, health systems, clinics, and other care providers that need to recruit, place, and manage clinical and administrative talent in a structurally tight labor market. The company was founded in 1985 and is headquartered in Dallas, Texas. Over time, it has built a broad platform by combining staffing, recruiting, and workflow support capabilities across several healthcare labor categories. AMN’s business is organized around three core lines. First, nurse and allied solutions, which includes travel nursing and allied health placements for hospitals and other care settings. Second, physician and leadership solutions, which covers locum tenens staffing, physician search, and executive/leadership recruitment. Third, the company’s language services and related technology-enabled offerings, which support communication, scheduling, and operational efficiency in healthcare environments. These services are designed to help clients address staffing shortages, improve fill rates, and manage labor costs more effectively. From a competitive standpoint, AMN is one of the better-known scaled players in US healthcare staffing. Its strengths lie in its national recruiting infrastructure, brand recognition, client relationships, breadth of service categories, and ability to offer integrated workforce solutions rather than a single-point staffing product. In a fragmented industry, scale matters: large hospital systems often prefer vendors that can support multiple staffing needs, data-driven workforce planning, and rapid deployment of talent. AMN therefore competes not only on price, but also on execution, speed, and the ability to deliver specialized clinicians and language support when demand spikes. Geographically, AMN is primarily exposed to the United States, which is also the key market for its investors. The business is closely tied to US healthcare utilization patterns, hospital budget conditions, and labor availability. Recent company communications in 2024 and 2025 indicate that AMN has been navigating a post-pandemic normalization in temporary staffing while emphasizing profitability discipline, balance sheet improvement, and a gradual shift toward more technology-enabled solutions. Recent results also highlight the importance of physician and leadership services and language services as more stable components of the portfolio. For investors, AMN is a cyclical but strategically relevant healthcare services platform with leverage to long-term shortages in clinical labor and the ongoing need for hospitals to manage workforce complexity.